35 citations · 35 across the 3 of their papers we have counts for
1 paper · 2 filters
Kentaro Takeda, Belay B. Yimer, Masahiro Kojima
The Bayesian optimal phase II (BOP2) design accommodates simple and complex endpoints but does not address biomarker-guided enrichment or multiplicity control across pooled and sub…